While 51% of salivary specimens (benign and malignant) tested were void of any MSANTD3 staining, strong MSANTD3 expression was observed in a substantial subset of mucoepidermoid carcinomas (5/25, 20%) and adenosquamous carcinomas (3/5, 60%). This evidence concerns the gene MSANTD3 and adenosquamous carcinoma.